Noradrenalin Abcur Innrennslisþykkni, lausn 1 mg/ml Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

noradrenalin abcur innrennslisþykkni, lausn 1 mg/ml

abcur ab* - noradrenalinum tartrat (norepinephrinum tartrat) - innrennslisþykkni, lausn - 1 mg/ml

Tibsovo Europos Sąjunga - islandų - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Æxlishemjandi lyf - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Simbrinza Europos Sąjunga - islandų - EMA (European Medicines Agency)

simbrinza

novartis europharm limited - skammtar, brimonidintartrat tartrat - ocular hypertension; glaucoma, open-angle - augnlækningar - minnkun á aukinni augnþrýstingi (iop) hjá fullorðnum sjúklingum með gláku í augnlokum eða augnháþrýstingi, þar sem einlyfjameðferð veitir ófullnægjandi blóðsykursfall.

Sibnayal Europos Sąjunga - islandų - EMA (European Medicines Agency)

sibnayal

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Brimonidin Bluefish Augndropar, lausn 2 mg/ml Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

brimonidin bluefish augndropar, lausn 2 mg/ml

bluefish pharmaceuticals ab - brimonidinum tartrat - augndropar, lausn - 2 mg/ml

Navelbine Mjúkt hylki 30 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

navelbine mjúkt hylki 30 mg

pierre fabre pharma norden ab - vinorelbinum tvítartrat - mjúkt hylki - 30 mg

Navelbine Mjúkt hylki 20 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

navelbine mjúkt hylki 20 mg

pierre fabre pharma norden ab - vinorelbinum tvítartrat - mjúkt hylki - 20 mg